MedPath

Effectiveness and safety of oral misoprostol Vs intravaginal PGE2 (Dinoprostone) for pre-induction cervical ripening in women with uncomplicated, singleton, post dated pregnancies: a randomized controlled study.

Phase 4
Completed
Conditions
Induction of labour
Registration Number
SLCTR/2021/022
Lead Sponsor
one
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

•Nulliparous pregnant women
•In a singleton pregnancy
•At 40 weeks and 5 days of gestation
•Fetus in cephalic presentation with intact membranes
•Modified bishop score(MBS) of < 5
•Not having any contraindications for vaginal delivery

Exclusion Criteria

•past caesarian delivery
•history of myomectomy
•hypersensitivity to misoprostol
•pregnancy induced hypertension
•gestational diabetes mellitus
•multiple pregnancies

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.